Skye Bioscience Inc (SKYE)
12.75
-0.16
(-1.24%)
USD |
NASDAQ |
May 07, 16:00
12.75
0.00 (0.00%)
After-Hours: 17:22
Skye Bioscience Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
July 31, 2014 | 72.69% |
April 30, 2014 | 67.59% |
January 31, 2014 | 67.64% |
October 31, 2013 | 62.22% |
Date | Value |
---|---|
July 31, 2013 | 65.03% |
April 30, 2013 | 59.99% |
January 31, 2013 | 56.97% |
October 31, 2012 | 67.03% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Cutera Inc | 12.60% |
Medical Marijuana Inc | 79.95% |
OrthoPediatrics Corp | 71.02% |
RAPT Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 48.70% |